Countries
Industry
Startup stage
Startup size
Funding
Impact startup SDGs
Showing: 11094 filtered startups

NEC OncoImmunity AS

OncoImmunity is a bioinformatics company providing unique machine-learning software to identify tumor-specific mutations that can be targeted by a patient’s own immune system (known as neoantigens). The OncoImmunity solution is important because recent breakthroughs in the field of Immuno-Oncology (I-O) such as the development of checkpoint inhibitors and personalized cancer vaccines, clearly demonstrate that a patient’s immune system can be harnessed to successfully treat cancer. The cost of identifying tumor-specific mutations in a patient’s cancer using next-generation sequencing (NGS) is now trivial and this technology will be key to enabling truly personalized immunotherapies to be developed in a technically and economically feasible manner. However, the remaining challenge that currently limits the field, and which is addressed by the OncoImmunity solution, is predicting which tumor-specific mutations can stimulate a patient’s immune system i.e. are immunogenic. Using NGS data as input, the OncoImmunity software enables accurate patient selection for cancer immunotherapy and can identify optimal targets for personalized cancer vaccines & cell therapies in a clinically actionable time frame. Beginning from this first product offering, OncoImmunity has the vision to become the world’s leading provider of software to guide cancer immunotherapy to improve survival rates for cancer patients. To achieve this OncoImmunity has assembled a growing team of world-class bioinformaticians, data scientists, and software engineers; developing its cutting-edge machine-learning technology that will help fulfill the promise of immunotherapy in the fight against cancer. OncoImmunity’s technology will disrupt the I-O field by offering regulatory-compliant prediction software on a software-as-a-service basis (SaaS). This will allow big pharma, biotechnology, and immunotherapy companies of any size to access OncoImmunity’s cutting-edge prediction software. The company is headquartered in an ideal scientific and entrepreneurial ecosystem to develop its technology at the Oslo Cancer Cluster Incubator; adjacent to the Institute for Cancer Research and the Norwegian Radium Hospital. OncoImmunity is a privately held company, founded in 2014 by experienced bioinformatics scientists (Dr. Trevor Clancy and Professor Eivind Hovig), and an experienced immunologist with a business development background (Dr. Richard Stratford). The company is backed by private financing from the Norwegian Radium Hospital Research Foundation, the Norwegian Cancer Society, STARTUPLAB, and Grotmol Solutions, in addition to a number of private software investors. The company is also supported by grants awarded from the Norwegian Research Council, Innovation Norway, and the EU. The company has already established both national and international collaborations and pilot projects to develop further proof-of-concept data and validate its software.

Hyre

Hyre is a car sharing company that launched the first version of the platform in 2018. We are a joint venture between Møller Mobility Group and Hyre Management, with MMG as the largest shareholder. Today we are the largest car sharing company in the Nordics with over 1600 shared cars. Quick and seamless customer journey With just one app, you can book, unlock and settle the car rental - without ever having to wait in line to pick up your car. Toll, fuel, and rental prices are automatically calculated in real time, providing you with a complete overview and eliminating time spent on administration and settlement. Our vehicles are always available and our mission is to never be more than 5 minutes away from where you are. The fleet of cars is owned and operated by Hyre witch gives us complete control over the customer journey to ensure predictable and safe access to modern cars at competitive prices. We believe in a future of shared, self-driving electric cars because: 1. The car itself changes. Today's cars are connected to the internet, enabling more efficient car sharing. Furthermore, the car is now electric and in due time it will be self-driven. 2. Demographics are changing. The car is no longer an important status symbol, and Hyre sees that today's youth do not want to own a car. People want simplicity, flexibility, and freedom. 3. Sustainability is a requirement. The way we move today is not sustainable. Even with electric cars, densification in the largest cities will force alternative solutions in people transport.

stormglass.io

stormglass.io is a global weather API company providing professional weather data to leading companies within the maritime industry, green energy production and agriculture. We believe that making high quality weather data easily accessible for everyone will have a significant positive impact on the climate. Our API service is used in a vast array of services impacting the climate such as reducing fuel consumption in shipping, optimizing green energy production and streamline agricultural operations.

Zerply

Zerply is a talent network for VFX and Animation where companies like Luma, Axis and Meta come to find the best talent. It's an entirely project driven industry where even the top artists go from project to project continually. We're a SaaS product with the most advanced talent sourcing toolset specifically built for the CG/VFX/Animation industry, which is heavily focused on portfolios and real time availability. Traditional tools like LinkedIn recruiter are great when the hiring process can take weeks or months, but not when you need to ramp up a creative team in a matter of days. It's not right that the industry creating the most iconic imagery on the planet is stuck with a manual hiring process from the 90s, running on spreadsheets and calling to check artist availability, and we're here to change that!

REKOM GROUP

REKOM is Scandinavia’s biggest nightlife group. We own and operate more than 200 nightlife venues across Denmark, Norway, Finland & UK – and there are more on the way. In REKOM, we have a clear ambition to stay one step ahead of the game. It’s not that hard, when we are more than 5000 dedicated employees working with carefully planned bar concepts and all of us deeply passionate about bringing atmosphere and soul to Scandinavian nightlife. Combined with more than 20 years of nightlife industry experience, the result speaks for itself: More than 8 million guests visit our bars, pubs and nightclubs every year! In 2018, REKOM’s growth plans were turbocharged as Danish private equity fund Catacap joined as part owner. The aim is now to become, not just Scandinavia’s, but Northern Europe’s biggest nightlife group. Career opportunities in REKOM are therefore plentiful in Denmark and on our other growing markets. In the REKOM family, you become part of a fun, strong community, you gain attractive employee benefits and the chance to develop and accelerate through our REKOM Academy and talent programs.

Wemuda

Wemuda is a venture studio and development agency based in Copenhagen. We are a team of in-house designers and developers dedicated to building high-quality software and digital experiences. Our expertise covers user experience design, mobile and web applications and enterprise-scale systems. Agile and adaptable, we work closely with our clients as long-term partners, delivering thoughtful solutions that evolve alongside your business needs.

Wayer

Wayer is a photo-sharing app for young people in Denmark aged 16-30 to exchange authentic pictures and videos from experiences they've had together in an easy and private way. When users are connected as friends, they get suggested to share memories if they've taken photos at the same time and place. This gives the users the opportunity to relive meaningful experiences from their life, helping them understand that they matter to others and thereby increasing their self-esteem. Backed by Antler: an early-stage VC with investments in more than 600 startups around the globe.

SASU

SASU er en livsstilstjeneste plattform som kobler kunder med tjenesteleverandører innen kategoriene skjønnhet, hår, fitness og helse. SASU er en plattform som gjør det enklere for kunder å komme i kontakt med profesjonelle tjenesteytere innen livsstil. Tjenestene vi fokuserer på er innen fitness, helse, skjønnhetspleie og hår. Med "når du vil, hvor du vil" mener vi at du kan be tjenesteyteren utføre tjenesten på en lokasjon av ditt valg - hjemme, på arbeidsplassen, i parken, på hotellet, osv. Du sender en forespørsel og tjenesteyteren godkjenner. Så enkelt er det! Å ta seg tid til selvpleie/egenpleie i en travel hverdag, kan være utfordrende. Slik bør det ikke være! Tjenesten SASU sitt formål er å gjøre det enklere for deg å prioritere egen velvære og helse. Via SASU kommer du i kontakt med mobile leverandører (“SASU Pro”) som kan møte deg der du er og da slipper du bl.a. upraktiske åpningstider, trafikk-kork og vansker med å finne en parkeringsplass. Våre leverandører (SASU Pro) og kunder er ID-sjekket. Og vi lar både tjenesteytere og kunder skrive anmeldelser og varsle til oss dersom noen har negativ atferd. "Livsstilstjenester der du er" er et nytt konsept som vi tester ut. Vi setter pris om du kan hjelpe oss å videreutvikle både konseptet og nettstedet sasu.no. Du kan gjøre dette ved å fortelle oss om hvordan du opplever nettstedet og hvordan du opplever å være kunde eller leverandør hos oss. Fortell oss gjerne også om vi kan tilby deg andre tjenester via nettstedet. Del gjerne dine tanker på hello@sasu.no.

myPlane

myPlane is making the future of air travel by digitalising airline charter flight enquiries, sales, distribution and management processes globally. Our unique and centralised digital marketplace platform is linking the aircraft supply and overcapacity with market demand, in real-time. The best routes, best schedules, most options and best prices – all in one centralised platform.

KÄÄPÄ Biotech Oy

About KÄÄPÄ Biotech, KÄÄPÄ Health, and KÄÄPÄ Forest: We are a startup committed to making both humans and ecosystems more healthy with the use of fungi. We take a biotech vision when designing solutions. We are the largest cultivator of chaga mushroom, have our own extraction product line for both consumers and a US distributor for ingredient sales, and work closely on bringing cutting edge research to market. Our company culture is demanding, fast paced, research focused, open, inclusive, and forward thinking.

XBTO Humla Ventures

XBTO Humla Ventures is a generalist fintech fund investing in the ‘picks and shovels’ that underpin the best fintech trends, with investments focused on digital asset ecosystems, financial products, AI and financial inclusion. As one of the largest and most trusted digital asset innovators and investors, we lead fintech ecosystem transformation and capture top-tier early stage opportunities. With our offices in New York, Miami, Paris and Gothenburg, we have a global geographic footprint that allows solid access to startups and market players. The firm's executives are regular public speakers and commentators on top media channels and events, and XBTO is the jersey sponsor of David Beckham’s Inter Miami Club Futbol.

DigiProc

Today a procurement organisation leaves 25-50 per cent of its spend un-negotiated. The reason is that this spend is spread out over hundreds or thousands of suppliers. We supplement the procurement organisation by running digital negotiations with these suppliers. Through our digital platform DigiProc scalable, efficient and smart negotiations are achieved without geographic or industry specific restrictions. We negotiate digitally with an unlimited number of your existing suppliers in a week. Only 20 hours of our customers time are required for a complete project from start to finish. And of course, - no software integration or similar is required.

Frankly Insure

Frankly Insure is a Danish venture-backed insurtech startup founded in 2021, building the future of insurance by delivering simple, affordable insurance solutions seamlessly embedded into everyday life. We’re an agile, fast-growing startup with a versatile and ambitious team, brought together by an urge to create something that people genuinely want and value. Our solution is already validated in the market, with customers and partners who love what we offer. Backed by top-tier investors, including Antler, Tenity, and a strong network of experienced investors, we’re now entering a new phase of rapid growth and looking for exceptional talent to help us accelerate.

Soul Bone

Soul Bone has since 2019 created and sold organic bone broth, primarily to customers with anti-imflammatory issues. We're not a food company but rather a health company. We use only the best available meats and vegetables, which also reflects on our high quality of product which is filled with collagen.

Kuatro Group

Ever wondered what it’s like to revolutionize pharmaceutical manufacturing with the power of AI? At Kuatro Group, we’re doing just that—and more. At Kuatro Group, we blend AI expertise with a deep understanding of the pharmaceutical industry. We don’t just drop consultants in to fix immediate issues; instead, we develop lasting solutions that let our clients focus on what truly matters. Our project-based method, combined with pharma-specific know-how, allows us to create modular “mini-products” that adapt smoothly across diverse challenges in the industry. Yet it’s our team spirit that truly stands out. We’re a smaller, close-knit group where people often gather around each other’s screens, debugging complex code or playfully comparing their favorite libraries. Our workspace in a dynamic Copenhagen co-office fuels collaboration, and regular innovation days encourage us to explore new techniques, refine existing solutions, and grow our skills—whether that’s co-programming a novel approach or evaluating how emerging tools can enhance our tried-and-true methods. If you’re excited about developing AI solutions that make a tangible difference in the life sciences—and want a place where your ideas can quickly go from concept to implementation—Kuatro Group might be exactly what you’re looking for. Join us, and let’s continue shaping the future of pharmaceutical innovation together.